Kraig Biocraft Laboratories, Inc. (KBLB)
OTCMKTS
· Delayed Price · Currency is USD
0.0900
+0.0005 (0.56%)
Oct 31, 2024, 4:00 PM EDT
KBLB Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 1.52 | 2.55 | 3.86 | 2.36 | 0.82 | 0.13 | Upgrade
|
| Short-Term Investments | - | - | 0.1 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 1.52 | 2.55 | 3.96 | 2.36 | 0.82 | 0.13 | Upgrade
|
| Cash Growth | -51.92% | -35.58% | 68.20% | 188.29% | 553.40% | 812.78% | Upgrade
|
| Inventory | 0.01 | 0.01 | 0.01 | - | - | - | Upgrade
|
| Prepaid Expenses | 0.01 | 0.01 | 0.02 | 0.01 | 0 | 0.03 | Upgrade
|
| Total Current Assets | 1.53 | 2.57 | 3.98 | 2.37 | 0.82 | 0.16 | Upgrade
|
| Property, Plant & Equipment | 0.13 | 0.16 | 0.15 | 0.22 | 0.45 | 0.59 | Upgrade
|
| Long-Term Investments | 0.56 | 0.49 | 0.44 | 0.44 | - | - | Upgrade
|
| Other Long-Term Assets | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Total Assets | 2.22 | 3.23 | 4.57 | 3.02 | 1.28 | 0.75 | Upgrade
|
| Accounts Payable | 0.52 | 0.54 | 0.54 | 0.59 | 3.43 | 3.16 | Upgrade
|
| Accrued Expenses | 3.26 | 3.13 | 2.7 | 4.96 | 1.71 | 1.31 | Upgrade
|
| Short-Term Debt | 1.62 | 1.65 | 1.71 | 2.16 | 1.8 | 0.64 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | 0.06 | 0.06 | 0.06 | Upgrade
|
| Current Portion of Leases | 0.06 | 0.04 | 0.04 | 0.04 | 0.12 | 0.11 | Upgrade
|
| Other Current Liabilities | 3.69 | 3.52 | 3.08 | 0.35 | 0.33 | 0.3 | Upgrade
|
| Total Current Liabilities | 9.15 | 8.89 | 8.07 | 8.16 | 7.45 | 5.58 | Upgrade
|
| Long-Term Debt | - | - | - | 0.1 | 0.15 | 0.19 | Upgrade
|
| Long-Term Leases | 0.05 | 0.05 | 0.02 | 0.06 | 0.25 | 0.37 | Upgrade
|
| Total Liabilities | 9.19 | 8.94 | 8.09 | 8.32 | 7.85 | 6.14 | Upgrade
|
| Common Stock | 27.41 | 27.41 | 27.08 | 22.39 | 17.12 | 16.76 | Upgrade
|
| Additional Paid-In Capital | 12.18 | 11.35 | 10.83 | 9.89 | 5.83 | 2.41 | Upgrade
|
| Retained Earnings | -51.8 | -49.69 | -46.66 | -42.81 | -34.77 | -29.8 | Upgrade
|
| Comprehensive Income & Other | - | - | - | 0.02 | 0.02 | 0.02 | Upgrade
|
| Total Common Equity | -12.21 | -10.92 | -8.74 | -10.51 | -11.79 | -10.61 | Upgrade
|
| Shareholders' Equity | -6.97 | -5.71 | -3.52 | -5.3 | -6.57 | -5.39 | Upgrade
|
| Total Liabilities & Equity | 2.22 | 3.23 | 4.57 | 3.02 | 1.28 | 0.75 | Upgrade
|
| Total Debt | 1.73 | 1.75 | 1.77 | 2.42 | 2.38 | 1.37 | Upgrade
|
| Net Cash (Debt) | -0.2 | 0.8 | 2.19 | -0.07 | -1.57 | -1.24 | Upgrade
|
| Net Cash Growth | - | -63.30% | - | - | - | - | Upgrade
|
| Net Cash Per Share | -0.00 | 0.00 | 0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| Filing Date Shares Outstanding | 1,038 | 1,038 | 1,033 | 950.91 | 854.41 | 844.47 | Upgrade
|
| Total Common Shares Outstanding | 1,038 | 1,038 | 1,031 | 927.38 | 854.41 | 844.47 | Upgrade
|
| Working Capital | -7.61 | -6.31 | -4.09 | -5.8 | -6.63 | -5.43 | Upgrade
|
| Book Value Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | Upgrade
|
| Tangible Book Value | -12.21 | -10.92 | -8.74 | -10.51 | -11.79 | -10.61 | Upgrade
|
| Tangible Book Value Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | Upgrade
|
| Machinery | 0.18 | 0.18 | 0.17 | 0.17 | 0.15 | 0.15 | Upgrade
|
| Leasehold Improvements | 0.08 | 0.08 | 0.08 | 0.08 | 0.09 | 0.09 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.